August 19, 2014

Nearly half of women age 45 years or older who experience symptoms of overactive bladder report their current treatment does not address their OAB symptoms, according to a recent survey conducted by The Harris Poll on behalf of Allergan.

February 4, 2013

Merz North America on Monday named Jim Hartman VP of the Merz Aesthetics business unit, which includes Xeomin, Radiesse and Belotero Balance.

November 21, 2010

Drug maker OcuSoft has launched a prescription supplement designed to enhance botulinum toxin injections, the...

October 17, 2010

A popular beauty treatment has won approval as a medical treatment as well....

August 1, 2010

The Food and Drug Administration has approved a treatment for muscle spasms and twitches....